C4 Therapeutics's total assets for Q4 2025 were $359.07M, an increase of 35.25% from the previous quarter. CCCC total liabilities were $102.49M for the fiscal quarter, a -7.73% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.